Increased serum CRH levels with decreased skin CRHR-1 gene expression in psoriasis and atopic dermatitis - 28/04/12
Doi : 10.1016/j.jaci.2012.01.041
Magdalini Vasiadi, BSc a, b, c, Anastasia Therianou, MD d, Kyriaki Sideri, MD c, Marilena Smyrnioti, BSc, MA e, Nikolaos Sismanopoulos, MD a, c, Danae A. Delivanis, MD a, l, Shahrzad Asadi, PharmD a, f, Alexandra Katsarou-Katsari, MD, PhD d, Theodora Petrakopoulou, MD g, Athanasios Theoharides, MD, PhD h, Christina Antoniou, MD, PhD d, Evaggelia Papadavid, MD, PhD i, Nikolaos Stavrianeas, MD, PhD i, Dimitrios Kalogeromitros, MD, PhD c, †, Theoharis C. Theoharides, MS, PhD, MD a, b, c, j, k 
a Molecular Immunopharmacology and Drug Discovery Laboratory, Department of Molecular Physiology and Pharmacology, Tufts University School of Medicine, Boston, Mass
j Department of Biochemistry, Tufts University School of Medicine, Boston, Mass
b Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Mass
c Allergy Clinical Research Center, Attikon Hospital, Athens University Medical School, Athens, Greece
e Pain Relief Clinic, Second Department of Anesthesiology, Attikon Hospital, Athens University Medical School, Athens, Greece
i Second Department of Dermatology, Attikon Hospital, Athens University Medical School, Athens, Greece
d First Department of Dermatology, A. Sygros Hospital, Athens University Medical School, Athens, Greece
f Department of Pharmacy, Tufts Medical Center, Tufts University School of Medicine, Boston, Mass
g Oncology Hospital, IKA, Athens, Greece
h Ano Toumba Polyclinic, IKA, Thessaloniki, Greece
k Department of Internal Medicine, Tufts University School of Medicine and Tufts Medical Center, Boston, Mass
l Department of Internal Medicine, University of Connecticut Medical Center, Hartford, Conn
| This work was supported in part by the National Institutes of Health grant AR47652 awarded to T.C.T. |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2012
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 129 - N° 5
P. 1410-1413 - mai 2012 Retour au numéro
Article précédent
- Specific allergen concentration of WHO and FDA reference preparations measured using a multiple allergen standard
- Stephanie Filep, Amy Tsay, Lisa D. Vailes, Gabriele Gadermaier, Fatima Ferreira, Elizabeth Matsui, Eva M. King, Martin D. Chapman
- Epistatic interaction between Toll-like receptor 3 (TLR3) and prostaglandin E receptor 3 (PTGER3) genes
- Mayumi Ueta, Gen Tamiya, Katsushi Tokunaga, Chie Sotozono, Masao Ueki, Hiromi Sawai, Tsutomu Inatomi, Toshiyuki Matsuoka, Shizuo Akira, Shuh Narumiya, Kei Tashiro, Shigeru Kinoshita
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?